Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Oct 17 - Oct 22
Pre-treatment considerations should include: Disease activity assessment : GLP-1 agonists should ideally be initiated when Crohn's disease is in remission or well-controlled, as distinguishing medication side effects from disease flare becomes challenging during active inflammation Nutritional status evaluation : Patients with Crohn's disease may already have compromised nutritional status
Vomiting Frequent vomiting can lead to fluid and electrolyte loss, compounding dehydration risk and potentially affecting overall blood viscosity
Nausea, constipation, and fatigue are common
Keep 3-6 months of medication costs in emergency savings
Not sure why many on these threads cant comprehend this
US$ 23.68
US$ 20.64
US$ 23.79
